CTLA4-Ig–Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function-Reference-Cited by-同舟云学术

CTLA4-Ig–Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function

Published:2021-01-25 Issue:5 Volume:206 Page:1102-1113
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Goenka Radhika^ORCID,Xu Zhenghai,Samayoa Josue,Banach David,Beam Christine,Bose Sahana,Dooner Gerri^ORCID,Forsyth Charles M.,Lu Xiaoqing,Medina Limary^ORCID,Sadhukhan Ramkrishna,Sielaff Bernhard,Sousa Silvino,Tao Qingfeng,Touw Debra,Wu Fei^ORCID,Kingsbury Gillian A.^ORCID,Akamatsu Yoshiko

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Molecular mechanisms of T cell co-stimulation and co-inhibition

2. CD28 is required for germinal center formation.;Ferguson;J. Immunol.,1996

3. B7-1 and B7-2 Have Overlapping, Critical Roles in Immunoglobulin Class Switching and Germinal Center Formation

4. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell–dependent B cell responses

5. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide transcriptional profiling and functional analysis of long noncoding RNAs and mRNAs in chicken macrophages associated with the infection of avian pathogenic E. coli;BMC Veterinary Research;2024-02-07

2. Metabolic reprogramming of myeloid-derived suppressor cells in the context of organ transplantation;Cytotherapy;2023-08

3. Tissue‐resident memory T cells and lung immunopathology;Immunological Reviews;2023-04-04

4. What do we know about co-stimulatory and co-inhibitory immune checkpoint signals in ankylosing spondylitis?;Clinical and Experimental Immunology;2023-03-08

5. Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes;Frontiers in Endocrinology;2023-01-10